Logo image of MCAF

MOUNTAIN CREST ACQ CORP IV (MCAF) Stock Fundamental Analysis

NASDAQ:MCAF - Nasdaq - US62403K1088 - Common Stock - Currency: USD

14.85  +1.36 (+10.08%)

Premarket: 6 -8.85 (-59.6%)

Fundamental Rating

1

Taking everything into account, MCAF scores 1 out of 10 in our fundamental rating. MCAF was compared to 0 industry peers in the Unkown industry. MCAF may be in some trouble as it scores bad on both profitability and health. MCAF does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MCAF was profitable.
MCAF had a negative operating cash flow in the past year.
MCAF Yearly Net Income VS EBIT VS OCF VS FCFMCAF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -200K -400K -600K

1.2 Ratios

Industry RankSector Rank
ROA 2.12%
ROE 2.91%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MCAF Yearly ROA, ROE, ROICMCAF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -0.5 -1 -1.5

1.3 Margins

MCAF does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MCAF Yearly Profit, Operating, Gross MarginsMCAF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

2

2. Health

2.1 Basic Checks

MCAF has a worse debt/assets ratio than last year.
MCAF Yearly Shares OutstandingMCAF Yearly Shares OutstandingYearly Shares Outstanding 2021 500K 1M 1.5M
MCAF Yearly Total Debt VS Total AssetsMCAF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 10M 20M 30M 40M 50M

2.2 Solvency

MCAF has an Altman-Z score of 1.05. This is a bad value and indicates that MCAF is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.12 indicates that MCAF is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 1.05
ROIC/WACCN/A
WACCN/A
MCAF Yearly LT Debt VS Equity VS FCFMCAF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 10M 20M 30M 40M 50M

2.3 Liquidity

A Current Ratio of 3.66 indicates that MCAF has no problem at all paying its short term obligations.
MCAF has a Quick Ratio of 3.66. This indicates that MCAF is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.66
Quick Ratio 3.66
MCAF Yearly Current Assets VS Current LiabilitesMCAF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

MCAF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 212.80%, which is quite impressive.
EPS 1Y (TTM)212.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MCAF Yearly Revenue VS EstimatesMCAF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022
MCAF Yearly EPS VS EstimatesMCAF Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 212.14, MCAF can be considered very expensive at the moment.
MCAF's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.62.
Industry RankSector Rank
PE 212.14
Fwd PE N/A
MCAF Price Earnings VS Forward Price EarningsMCAF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MCAF Per share dataMCAF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MCAF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOUNTAIN CREST ACQ CORP IV

NASDAQ:MCAF (3/28/2024, 8:23:22 PM)

Premarket: 6 -8.85 (-59.6%)

14.85

+1.36 (+10.08%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.20M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 212.14
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.43
P/tB 0.43
EV/EBITDA N/A
EPS(TTM)0.07
EY0.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS0
BVpS34.56
TBVpS34.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.12%
ROE 2.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.66
Quick Ratio 3.66
Altman-Z 1.05
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)212.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-136.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-136.36%
OCF growth 3YN/A
OCF growth 5YN/A